- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Glaxo Smith Kline (BIOC)
Glaxo Smith Kline stock price live, this page displays EGX BIOC stock exchange data. View the BIOC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Glaxo Smith Kline real time stock price chart below.
What Is the Glaxo Smith Kline Stock Price Today?
The Glaxo Smith Kline stock price today is 48.35.
What Is the Stock Symbol for Glaxo Smith Kline?
The stock symbol for Glaxo Smith Kline is ""BIOC.""
What Stock Exchange Does Glaxo Smith Kline Trade On?
Glaxo Smith Kline is listed and trades on the Egypt stock exchange.
Is Glaxo Smith Kline a Good Stock to Buy?
Determining whether Glaxo Smith Kline—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOC quote. (ISIN: EGS38171C012)
What Is the Glaxo Smith Kline Stock Price Today?
The Glaxo Smith Kline stock price today is 48.35.
What Is the Stock Symbol for Glaxo Smith Kline?
The stock symbol for Glaxo Smith Kline is ""BIOC.""
What Stock Exchange Does Glaxo Smith Kline Trade On?
Glaxo Smith Kline is listed and trades on the Egypt stock exchange.
Is Glaxo Smith Kline a Good Stock to Buy?
Determining whether Glaxo Smith Kline—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOC quote. (ISIN: EGS38171C012)
Egypt
Currency in EGP
48.35
-0.01(-0.02%)
Closed·
Fair Value
An estimate of a Glaxo Smith Kline's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.20
49.85
52 wk Range
27.01
50.79
BIOC Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
BIOC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Glaxo Smith Kline's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.2049.85
52 wk Range
27.0150.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BIOC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Glaxo Smith Kline's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Glaxo Smith Kline Company Profile
GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.
Compare BIOC to Peers and Sector
Metrics to compare | BIOC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.7x | 8.1x | −0.5x | |
PEG Ratio | 0.03 | 0.01 | 0.00 | |
Price/Book | 1.9x | 2.5x | 2.6x | |
Price / LTM Sales | 1.2x | 2.1x | 3.3x | |
Upside (Analyst Target) | - | 138.1% | 43.4% | |
Fair Value Upside | Unlock | 18.4% | 7.1% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
0.71 / --
Revenue / Forecast
993.91M / --
People Also Watch
FAQ
What Stock Exchange Does Glaxo Smith Kline Trade On?
Glaxo Smith Kline is listed and trades on the Egypt Stock Exchange stock exchange.
What Is the Stock Symbol for Glaxo Smith Kline?
The stock symbol for Glaxo Smith Kline is "BIOC."
What Is the Glaxo Smith Kline Market Cap?
As of today, Glaxo Smith Kline market cap is 4.04B.
What Is Glaxo Smith Kline's Earnings Per Share (TTM)?
The Glaxo Smith Kline EPS (TTM) is 2.90.
From a Technical Analysis Perspective, Is BIOC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Glaxo Smith Kline Stock Split?
Glaxo Smith Kline has split 1 times.
How Many Employees Does Glaxo Smith Kline Have?
Glaxo Smith Kline has 800 employees.
What is the current trading status of Glaxo Smith Kline (BIOC)?
As of 10 Aug 2025, Glaxo Smith Kline (BIOC) is trading at a price of 48.35, with a previous close of 48.36. The stock has fluctuated within a day range of 48.20 to 49.85, while its 52-week range spans from 27.01 to 50.79.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.